First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia

Published:2019-04-21 Issue:1 Volume:18 Page:12-21
ISSN:2414-9314
Container-title:Pediatric Hematology/Oncology and Immunopathology
language:
Short-container-title:Voprosy gematologii/onkologii i immunopatologii v pediatrii

Author:

Dyakonova Yu. Yu.¹^ORCID,Myakova N. V.¹^ORCID,Litvinov D. V.¹^ORCID,Shelikhova L. N.¹^ORCID,Maschan M. A.¹^ORCID,Abugova Yu. G.¹^ORCID,Fominykh V. V.¹^ORCID,Yevstratov D. A.¹^ORCID,Bydanov O. I.²^ORCID,Kurnikova E. E.¹^ORCID,Popov A. M.¹^ORCID,Olshanskaya Yu. V.¹^ORCID,Karachunsky А. I.¹^ORCID

Affiliation:

1. Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation

2. Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation; Republican Research Center for Pediatric Oncology, Hematology and Immunology

Publisher

Fund Doctors, Innovations, Science for Children

Subject

Oncology,Hematology,Immunology,Immunology and Allergy,Pediatrics, Perinatology, and Child Health

Reference23 articles.

1. Man L.M., Morris A.L., Keng M. New Therapeutic Strategies in Acute Lymphocytic Leukemia. Curr Hematol Malig Rep 2017; 12 (3): 197-206.

2. Henze G., v Stackelberg A., Eckert C. ALL-REZ BFM - the consecutive trials for children with relapsed acute lymphoblastic leukemia. Klin Padiatr 2013; 225 (Suppl 1): S73-8.

3. Gandhi V., Plunkett W., Weller S., Du M., Ayres M., Rodriguez C.O.Jr., et al. Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells. J Clin Oncol 2001 Apr 15; 19 (8): 2142-52.

4. D'yakonova Yu.Yu., Bydanov O.I., Myako-va N.V., Abugova Yu.G, Aleinikova O.V., Arakaev O.R. Rezul'taty protivoretsidivnoi terapii ostrogo limfoblastonogo deikoza u detei po pilotnomu protokolu ALL-REZ-MB-2014. Voprosy gematologii/onkologii i immunopatologii v pediatrii 2017; 16 (3): 7-14.

5. Szczepanek J., Pogorzala M., Konat-kowska B., Juraszewska E., Badow-ska W., Olejnik I., Kuzmicz M. Differential ex vivo activity of bortezomib in newly diagnosed paediatric acute lymphoblastic and myeloblastic leukaemia. Anticancer Res 2010; 30 (6): 2119-24.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience;Pediatric Hematology/Oncology and Immunopathology;2023-02-14